C&R Research Inc. (KOSDAQ:359090)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,009.00
-1.00 (-0.10%)
Last updated: Sep 19, 2025, 11:29 AM KST

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
Clinical Trials for Licensing
42.29B
Log In
Log In
Log In
Clinical Trials for Licensing Growth
14.31%
Log In
Log In
Log In
Non-licensed Clinical Trials
11.91B
Log In
Log In
Log In
Non-licensed Clinical Trials Growth
-1.76%
Log In
Log In
Log In
Other Service
5.48B
Log In
Log In
Log In
Other Service Growth
-8.29%
Log In
Log In
Log In
Rental
11.00M
Log In
Log In
Log In
Rental Growth
-8.33%
Log In
Log In
Log In
Services
-
Log In
Log In
Log In
Delivery
-
Log In
Log In
Log In
Goods
-
Log In
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
South Korea
59.28B
Log In
Log In
Log In
South Korea Growth
8.11%
Log In
Log In
Log In
Overseas
404.15M
Log In
Log In
Log In
Overseas Growth
52.61%
Log In
Log In
Log In